Ionis Pharmaceuticals, Inc. (LON:0JDI)
London · Delayed Price · Currency is GBP · Price in USD 61.11
-2.61 (-4.09%)
At close: Sep 15, 2025
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
644.59K GBP
Profits / Employee
-183.13K GBP
Market Cap
7.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | 660 | -97 | -12.81% |
| Dec 31, 2020 | 757 | -60 | -7.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Ionis Pharmaceuticals News
- 4 days ago - Ionis expands Surf Away+ event, marking 10 years of creating unique adaptive experiences for people with neurological diseases - Business Wire
- 4 days ago - Insider Sell: Patrick O'neil Sells 21,000 Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 5 days ago - Ionis: Recent Approvals, Upcoming Catalysts To Spur Strong Upside (Rating Upgrade) - Seeking Alpha
- 6 days ago - Ionis Pharmaceuticals, Inc. (IONS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 days ago - Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status - Benzinga
- 6 days ago - Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status - Benzinga
- 6 days ago - Ionis gets FDA breakthrough therapy status for angelman syndrome drug - Seeking Alpha
- 6 days ago - Ionis Pharmaceuticals Inc (IONS) Receives FDA Breakthrough Therapy Designation for ION582 | ... - GuruFocus